These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6718347)

  • 1. [Changes in the lipid metabolic indices as affected by tuberculosis and the action of antitubercular preparations in an experiment].
    Solov'eva TN; Malakhova MIa
    Probl Tuberk; 1984 Mar; (3):56-60. PubMed ID: 6718347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
    Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
    Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the biological properties of Mycobacterium tuberculosis as affected by x-ray radiation].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1986; (9):47-50. PubMed ID: 3097634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of alternating treatment of tuberculosis (experimental studies)].
    Drabkina RO
    Probl Tuberk; 1976; 3():62-7. PubMed ID: 967862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamics of the rosette formation indices in the experimental tuberculosis chemotherapy process].
    Sibirnaia RI
    Probl Tuberk; 1981 Jun; (6):54-7. PubMed ID: 7279911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipoprotein metabolic study of pulmonary tuberculosis during antibacterial treatment].
    Liudvichek IA
    Probl Tuberk; 1982 Sep; (9):67-71. PubMed ID: 7145922
    [No Abstract]   [Full Text] [Related]  

  • 7. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 8. [The new generation of antitubercular preparations].
    Chuchalin AG
    Probl Tuberk; 2000; (5):6-8. PubMed ID: 11077842
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
    Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
    [No Abstract]   [Full Text] [Related]  

  • 10. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests].
    Kanei T; Kondo E
    Kekkaku; 1983 Apr; 58(4):235-45. PubMed ID: 6632485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological reactivity during the pathogenetic treatment of experimental tuberculosis].
    Sibirnaia RI; Snitinskaia OS
    Vrach Delo; 1990 Feb; (2):77-9. PubMed ID: 2339563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitubercular activity of prothionamide-isoiazid combination. Experimental study].
    Arzu G; De Santis G; Ginesu F
    G Ital Chemioter; 1967; 14(1):58-64. PubMed ID: 5622726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the biotin and inositol content of tissues of healthy and tubercular guinea pigs during administration of antibacterial preparations].
    Kruchakova FA
    Probl Tuberk; 1970; 48(7):49-54. PubMed ID: 5486082
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of antioxidants and lidase in pulmonary tuberculosis].
    Gur'eva IG; Andrzheiuk NI; Starostenko EV; Smirnova NA; Elistratova NA
    Probl Tuberk; 1988; (1):52-6. PubMed ID: 3362823
    [No Abstract]   [Full Text] [Related]  

  • 17. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
    Showalter HD; Denny WA
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New data on short-term antitubercular chemotherapy].
    Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(1):3-7. PubMed ID: 191888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG
    Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of experimental use of antitubercular preparations and various pathogenetic drugs on the immunological reactions of the body].
    Beliakova OI; Kharakter ZhZ; Sibirnaia RI; Snitinskaia OS
    Probl Tuberk; 1988; (4):65-8. PubMed ID: 3262223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.